Vaxcyte, Inc. PCVX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s common stock?
- Vaxcyte, Inc. (PCVX) reported common stock of 500M in Q1 2026.
- How has Vaxcyte, Inc.'s common stock changed year-over-year?
- Vaxcyte, Inc.'s common stock decreased by 0.0% year-over-year, from 500M to 500M.
- What is the long-term trend for Vaxcyte, Inc.'s common stock?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s common stock has grown at a 521.3% compound annual growth rate (CAGR), from 54K to 500M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).